Table 3.
Acceptable % (95% CI) | Unadjusted OR (95% CI) | Adjusted Model 1a OR (95% CI) | Adjusted Model 2b OR (95% CI) | |
---|---|---|---|---|
Control n = 472 | 43.4 (38.9–48.0) | Reference | Reference | Reference |
Timeline n = 462 | 47.4 (42.8–52.1) | 1.17 (0.91–1.52) | 1.28 (0.98–1.68) | 0.86 (0.51–1.46) |
If HPV positive n = 490 | 48.4 (43.9–52.9) | 1.22 (0.95–1.57) | 1.33 (1.02–1.74) | 1.59 (0.89–2.87) |
Accuracy n = 472 | 55.3 (50.7–59.8) | 1.61 (1.25–2.08) | 1.74 (1.33–2.27) | 1.99 (1.11–3.59) |
Safety n = 461 | 57.0 (52.4–61.6) | 1.73 (1.34–2.24) | 1.93 (1.47–2.53) | 0.97 (0.56–1.68) |
Speed of cell changes n = 457 | 63.2 (58.6–67.7) | 2.24 (1.72–2.92) | 2.50 (1.90–3.30) | 0.89 (0.52–1.54) |
a Adjusted for age, education, vaccine status, screening status, knowledge score and timeline beliefs.
Adjusted for age, education, vaccine status and screening status.